Schonfeld Strategic Advisors LLC Gossamer Bio, Inc. Transaction History

Schonfeld Strategic Advisors LLC

  • $13.8 Billion
  • Q3 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 236,600 shares of GOSS stock, worth $198,744. This represents 0.0% of its overall portfolio holdings.

Number of Shares
236,600
Previous 1,156,236 79.54%
Holding current value
$198,744
Previous $1.04 Million 77.5%
% of portfolio
0.0%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$0.79 - $1.25 $726,512 - $1.15 Million
-919,636 Reduced 79.54%
236,600 $234,000
Q2 2024

Aug 14, 2024
BUY
$0.51 - $1.27 $497,595 - $1.24 Million
975,678 Added 540.37%
1,156,236 $1.04 Million
Q1 2024

May 15, 2024
SELL
$0.8 - $1.51 $151,281 - $285,544
-189,102 Reduced 51.16%
180,558 $213,000
Q4 2023

Feb 14, 2024
BUY
$0.48 - $1.08 $4,684 - $10,540
9,760 Added 2.71%
369,660 $336,000
Q3 2023

Nov 14, 2023
SELL
$0.78 - $1.82 $19,890 - $46,410
-25,500 Reduced 6.62%
359,900 $298,000
Q2 2023

Aug 14, 2023
SELL
$0.98 - $1.53 $6,272 - $9,792
-6,400 Reduced 1.63%
385,400 $462,000
Q1 2023

May 15, 2023
SELL
$0.96 - $2.92 $491,232 - $1.49 Million
-511,700 Reduced 56.64%
391,800 $493,000
Q4 2022

Feb 14, 2023
BUY
$1.74 - $12.87 $1.35 Million - $9.96 Million
774,156 Added 598.52%
903,500 $1.96 Million
Q3 2022

Nov 14, 2022
BUY
$7.21 - $14.88 $660,205 - $1.36 Million
91,568 Added 242.4%
129,344 $1.55 Million
Q2 2022

Aug 15, 2022
SELL
$5.97 - $9.97 $345,209 - $576,505
-57,824 Reduced 60.49%
37,776 $315,000
Q1 2022

May 16, 2022
SELL
$8.44 - $12.49 $227,036 - $335,981
-26,900 Reduced 21.96%
95,600 $830,000
Q4 2021

Feb 14, 2022
BUY
$10.12 - $14.07 $224,663 - $312,354
22,200 Added 22.13%
122,500 $1.39 Million
Q3 2021

Nov 16, 2021
BUY
$7.25 - $13.23 $727,175 - $1.33 Million
100,300 New
100,300 $1.26 Million
Q2 2021

Aug 16, 2021
SELL
$8.0 - $9.75 $399,216 - $486,544
-49,902 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$8.63 - $10.94 $52,297 - $66,296
6,060 Added 13.82%
49,902 $461,000
Q4 2020

Feb 16, 2021
BUY
$8.3 - $13.59 $363,888 - $595,812
43,842 New
43,842 $423,000

Others Institutions Holding GOSS

# of Institutions
108
Shares Held
167M
Call Options Held
430K
Put Options Held
519K
View Full List

About Gossamer Bio, Inc.

GOSS Quotes by TradingView
  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $78.9M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email